Global Myasthenia Gravis Market Forecast 2019-2027 - Market Size, Drivers, Trends, And Competitors

The global myasthenia gravis market, valued at US$ 1.2 Bn in 2018, is poised for substantial growth with an anticipated CAGR of 8.0% from 2019 to 2027. A recent report by Transparency Market Research highlights the driving forces and challenges shaping this dynamic landscape.

Driving Factors:

1. Rise in Research & Development Focus and Autoimmune Disorder Prevalence:

Autoimmune disorders, commonly affecting older men and young adult women, are witnessing a surge due to an increase in the geriatric population.
Myasthenia gravis, an autoimmune neuromuscular disorder, affects voluntary muscles. Approximately 20 in 100,000 people in the U.S. are diagnosed with myasthenia gravis each year.
The absence of a definite cure for myasthenia gravis has led to a strong focus on research and development, driving investments from key players in the quest for new therapies and medications.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=26105

2. Increase in Healthcare Infrastructure:

Global healthcare expenditure rise, coupled with an increase in per capita income, is driving the demand for costly treatments such as plasma exchange and intravenous immunoglobulin (IVIG) therapies.
Developing countries are witnessing significant investments in healthcare infrastructure modernization, leading to increased access to advanced treatments like monoclonal antibodies and IVIG therapies.

Challenges:

1. Expensive Treatment Options:

The discovery and development of new therapeutics incur high costs and lengthy commercialization timelines.
Costly treatments like IVIG and monoclonal antibodies pose financial challenges, impacting the selection of treatment options.

2. Chronic Side Effects:

Serious side effects associated with IVIG preparations, including flushing, muscle cramps, chills, and chest pain, may lead to treatment discontinuation, restraining market growth.

Competitive Landscape:

1. Leading Players:

The global myasthenia gravis market is highly fragmented, featuring both international and regional players.
Key market players include Alexion Pharmaceutical Inc., Avadel Pharmaceuticals, PLC., CSL Behring, Grifols, S.A., Baxter International, Inc., Shire plc, Novartis AG, F. Hoffmann-La Roche AG, Takeda Pharmaceutical Company Limited, and Valeant Pharmaceuticals International, Inc.

2. Industry Innovation:

Players like Stonex have standardized Indian marble at 20mm thickness, showcasing the industry's commitment to quality and innovation.
Ongoing research and development activities, coupled with advancements in extraction methods, contribute to a positive market trajectory.

Future Outlook:

1. Growth Potential:

The global myasthenia gravis market holds substantial growth potential, driven by factors such as increasing prevalence of autoimmune disorders, emphasis on research and development, and improving healthcare infrastructure.

2. Innovations and Advancements:

Innovations in treatments and therapeutic options are expected to shape the future of the myasthenia gravis market, offering new hope to patients globally.

𝐁𝐮𝐲 𝐭𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 | 𝐈𝐦𝐦𝐞𝐝𝐢𝐚𝐭𝐞 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐀𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 𝐚𝐭 - https://www.transparencymarketresearch.com/checkout.php?rep_id=26105<ype=S

the global myasthenia gravis market stands at the forefront of medical advancements, navigating challenges while unlocking new avenues for treatment, research, and innovation. As stakeholders continue to invest in the quest for effective therapies, the market is poised for transformative growth in the coming years.

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

Contact Us

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.